1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. South Carolina >
  6. DARA BioSciences Acquires Oncogenerix

M&A Deal Summary

DARA BioSciences Acquires Oncogenerix

On January 17, 2012, DARA BioSciences acquired life science company Oncogenerix

Acquisition Highlights
  • This is DARA BioSciences’ 2nd transaction in the Life Science sector.
  • This is DARA BioSciences’ 2nd transaction in the United States.
  • This is DARA BioSciences’ 1st transaction in South Carolina.

M&A Deal Summary
Date 2012-01-17
Target Oncogenerix
Sector Life Science
Buyer(s) DARA BioSciences
Deal Type Add-on Acquisition

Target

Oncogenerix

Mount Pleasant, South Carolina, United States
Oncogenerix, Inc. is a specialty pharmaceutical company.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

DARA BioSciences

Raleigh, North Carolina, United States
Category Company
Founded 2002
Sector Life Science
Employees15
Revenue 1M USD (2014)
DESCRIPTION

DARA BioSciences, Inc. is a clinical stage pharmaceutical development company that acquires high quality, promising therapeutic molecules in early stage development (late pre-clinical or Phase 1).

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 2 of 2
State: South Carolina M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2012 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-02-12 Point Therapeutics

Wellesley Hills, Massachusetts, United States

Point Therapeutics, Inc. is a bio-pharmaceutical company.

Buy -
Mergr

Solution for

Product

Company

Legal